Clinical Trial Update: Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated everolimus for epilepsy in patients with tuberous sclerosis complex; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Tuberous Sclerosis Complex

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Epilepsy, Tuberous Sclerosis Complex | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-09-23